Bradley Hintze
Bradley Hintze
Duke University
Verified email at hintze.org
Title
Cited by
Cited by
Year
Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix
D Liebschner, PV Afonine, ML Baker, G Bunkóczi, VB Chen, TI Croll, ...
Acta Crystallographica Section D: Structural Biology 75 (10), 861-877, 2019
8002019
MolProbity: More and better reference data for improved all‐atom structure validation
CJ Williams, JJ Headd, NW Moriarty, MG Prisant, LL Videau, LN Deis, ...
Protein Science 27 (1), 293-315, 2018
7322018
The crystal structure of Mtr4 reveals a novel arch domain required for rRNA processing
RN Jackson, AA Klauer, BJ Hintze, H Robinson, A Van Hoof, SJ Johnson
The EMBO journal 29 (13), 2205-2216, 2010
1082010
Molprobity's ultimate rotamer‐library distributions for model validation
BJ Hintze, SM Lewis, JS Richardson, DC Richardson
Proteins: Structure, Function, and Bioinformatics 84 (9), 1177-1189, 2016
752016
New insights into Hoogsteen base pairs in DNA duplexes from a structure-based survey
H Zhou, BJ Hintze, IJ Kimsey, B Sathyamoorthy, S Yang, JS Richardson, ...
Nucleic acids research 43 (7), 3420-3433, 2015
502015
Model validation: local diagnosis, correction and when to quit
JS Richardson, CJ Williams, BJ Hintze, VB Chen, MG Prisant, LL Videau, ...
Acta Crystallographica Section D: Structural Biology 74 (2), 132-142, 2018
222018
CaBLAM: Identification and scoring of disguised secondary structure at low resolution
CJ Williams, BJ Hintze, DC Richardson, JS Richardson
Comput. Crystallogr. Newsl. 4, 33, 2013
112013
Cis-nonPro peptides: Genuine occurrences and their functional roles
CJ Williams, LL Videau, DC Richardson, JS Richardson
BioRxiv, 324517, 2018
92018
Comparison of annotation services for next-generation sequencing in a large-scale precision oncology program
E Katsoulakis, JE Duffy, B Hintze, NL Spector, MJ Kelley
JCO Precision Oncology 4, 212-221, 2020
82020
Genomic analysis of metastatic solid tumors in veterans: findings from the VHA National Precision Oncology Program
PJ Poonnen, JE Duffy, B Hintze, M Shukla, TS Brettin, NR Conrad, H Yoo, ...
JCO Precision Oncology 3, 1-13, 2019
82019
Mismodeled purines: implicit alternates and hidden Hoogsteens
BJ Hintze, JS Richardson, DC Richardson
Acta Crystallographica Section D: Structural Biology 73 (10), 852-859, 2017
52017
Implementation of precision oncology in the Veterans Health Administration (VHA).
MJ Kelley, J Duffy, BJ Hintze, CD Williams, NL Spector
Journal of Clinical Oncology 35 (15_suppl), 6507-6507, 2017
32017
ResDe: a new tool for visual definition of distance restraints for crystallographic refinement
BJ Hintze, SJ Johnson
Journal of Applied Crystallography 43 (6), 1540-1542, 2010
32010
Medical oncologists’ perspectives of the Veterans Affairs National Precision Oncology Program
V Vashistha, PJ Poonnen, JL Snowdon, HG Skinner, V McCaffrey, ...
Plos one 15 (7), e0235861, 2020
22020
The Veterans Health Administration Precision Oncology Program for Advanced Prostate Cancer Patients: Expanding tumor NGS opportunities to a broader patient population.
A Sokolova, HH Cheng, BJ Hintze, MJ Kelley, NL Spector, J Duffy, ...
Journal of Clinical Oncology 37 (7_suppl), 193-193, 2019
22019
Association of mutational profile and human papillomavirus status in patients with head and neck squamous cell carcinoma
S Doerstling, D Winski, B Hintze, PJ Poonnen, JE Duffy, J Snowdon, ...
JOURNAL OF MOLECULAR DIAGNOSTICS 21 (6), 1204-1204, 2019
12019
Barriers to Prescribing Targeted Therapies for Patients With NSCLC With Highly Actionable Gene Variants in the Veterans Affairs National Precision Oncology Program
V Vashistha, J Armstrong, D Winski, PJ Poonnen, B Hintze, M Price, ...
JCO oncology practice, OP. 20.00703, 2021
2021
EGFR mutation testing and TKI treatment patterns among veterans with stage III and IV non-small cell lung cancer
A Hung, KM Lee, PR Alba, Y Li, AZ Gao, BJ Hintze, OV Efimova, ...
Cancer Treatment and Research Communications 27, 100327, 2021
2021
Barriers to prescribing targeted therapies for NSCLC patients with highly actionable gene variants in the VA National Precision Oncology Program.
V Vashistha, J Armstrong, D Winski, M Price, BJ Hintze, P Poonnen, ...
Journal of Clinical Oncology 38 (15_suppl), 2005-2005, 2020
2020
HSR20-086: Concurrent Chemoradiation Treatment Patterns for Stage III Non-Small Cell Lung Cancer in Veterans
A Hung, KM Lee, Y Li, JA Lynch, P Poonnen, BJ Hintze, OV Efimova, ...
Journal of the National Comprehensive Cancer Network 18 (3.5), HSR20-086 …, 2020
2020
The system can't perform the operation now. Try again later.
Articles 1–20